William Blair & Company’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,307
| Closed | -$284K | – | 1860 |
|
|
2024
Q1 | $284K | Buy |
10,307
+57
| +0.6% | +$1.57K | ﹤0.01% | 1276 |
|
|
2023
Q4 | $313K | Buy |
10,250
+1,000
| +11% | +$30.5K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $292K | Hold |
9,250
| – | – | ﹤0.01% | 1245 |
|
|
2023
Q2 | $377K | Buy |
9,250
+2,000
| +28% | +$81.6K | ﹤0.01% | 1158 |
|
|
2023
Q1 | $270K | Sell |
7,250
-110
| -1% | -$4.1K | ﹤0.01% | 1283 |
|
|
2022
Q4 | $257K | Sell |
7,360
-3,178
| -30% | -$111K | ﹤0.01% | 1284 |
|
|
2022
Q3 | $590K | Buy |
10,538
+178
| +2% | +$9.97K | ﹤0.01% | 984 |
|
|
2022
Q2 | $536K | Sell |
10,360
-2
| -0% | -$103 | ﹤0.01% | 1041 |
|
|
2022
Q1 | $753K | Buy |
10,362
+1,100
| +12% | +$79.9K | ﹤0.01% | 1020 |
|
|
2021
Q4 | $1.1M | Buy |
9,262
+152
| +2% | +$18K | ﹤0.01% | 923 |
|
|
2021
Q3 | $1.22M | Hold |
9,110
| – | – | ﹤0.01% | 853 |
|
|
2021
Q2 | $1.48M | Hold |
9,110
| – | – | 0.01% | 805 |
|
|
2021
Q1 | $731K | Buy |
9,110
+1,000
| +12% | +$80.2K | ﹤0.01% | 1002 |
|
|
2020
Q4 | $441K | Buy |
+8,110
| New | +$441K | ﹤0.01% | 1118 |
|
|
2019
Q4 | – | Sell |
-19,730
| Closed | -$263K | – | 1778 |
|
|
2019
Q3 | $263K | Hold |
19,730
| – | – | ﹤0.01% | 1174 |
|
|
2019
Q2 | $323K | Sell |
19,730
-2,530
| -11% | -$41.4K | ﹤0.01% | 1130 |
|
|
2019
Q1 | $380K | Buy |
22,260
+200
| +0.9% | +$3.41K | ﹤0.01% | 1056 |
|
|
2018
Q4 | $301K | Buy |
22,060
+12,060
| +121% | +$165K | ﹤0.01% | 1081 |
|
|
2018
Q3 | $286K | Sell |
10,000
-6,000
| -38% | -$172K | ﹤0.01% | 1157 |
|
|
2018
Q2 | $438K | Buy |
+16,000
| New | +$438K | ﹤0.01% | 986 |
|